Table 1.
Metabolites identified as individually statistically significantly different during chemotherapeutic treatment using two-way ANOVA for OCCs and OCSCs
| Metabolite | Group | Time | Interactions | ||
|---|---|---|---|---|---|
| OCC | Control vs IC50 vs 1.5 × IC50 | 2-Butyl-1-octanol | 6.88E-04 | 1.48E-07 | 1.96E-07 |
| Hexadecane | 2.83E-03 | 4.81E-11 | 0.831 | ||
| D-Glucose | 2.83E-03 | 7.21E-03 | 1.73E-03 | ||
| Uracil | 4.50E-03 | 1.05E-11 | 1.96E-07 | ||
| L-Tyrosine | 6.00E-03 | 6.35E-08 | 2.26E-03 | ||
| Erythronic acid | 7.07E-03 | 6.16E-03 | 0.424 | ||
| Xylobiose | 0.047 | 0.140 | 0.162 | ||
| Control vs IC50 | 2-Butyl-1-octanol | 0.016 | 3.03E-06 | 4.81E-05 | |
| Uracil | 0.039 | 4.28E-07 | 1.53E-04 | ||
| D-Glucose | 0.039 | 1.07E-03 | 0.011 | ||
| Hexadecane | 0.041 | 1.93E-07 | 0.766 | ||
| L-Tyrosine | 0.041 | 2.01E-06 | 1.19E-03 | ||
| Erythronic acid | 0.041 | 0.089 | 0.644 | ||
| Erythritol | 0.041 | 0.281 | 0.484 | ||
| Control vs 1.5 × IC50 | Uracil | 0.025 | 2.84E-08 | 3.09E-06 | |
| Hexadecane | 0.025 | 3.41E-07 | 0.510 | ||
| L-Tyrosine | 0.025 | 1.05E-04 | 0.013 | ||
| D-Glucose | 0.025 | 0.041 | 7.10E-03 | ||
| Erythronic acid | 0.025 | 0.098 | 0.496 | ||
| OCSC | Ethanolamine | 4.82E-03 | 2.76E-05 | 1.39E-05 | |